Appendix 22b Appendix 22b: 2009 Pharmacological study characteristics tables Please note that some of the references and the data in this appendix have been incorporated from the previous guideline and have therefore not been updated to reflect current house style. Full terms of abbreviations are listed at the back of the guideline, except in some instances where they are explained in situ. An asterisk next to an author’s name indicates that their study is the primary study. Contents Initial treatment with antipsychotic medication ............................................................................................................................................................................................... 7 Characteristics of included studies (previous guideline) ......................................................................................................................................................................... 7 Emsley1995 ..................................................................................................................................................................................................................................................... 7 Jones1998 ......................................................................................................................................................................................................................................................... 7 References of included studies (previous guideline) ................................................................................................................................................................................ 7 Characteristics of included studies (update).............................................................................................................................................................................................. 8 DEHAAN2003 ................................................................................................................................................................................................................................................ 8 LEE2007 ......................................................................................................................................................................................................................................................... 10 LIEBERMAN2003A ..................................................................................................................................................................................................................................... 12 MCEVOY2007A ........................................................................................................................................................................................................................................... 15 MOLLER2008 ............................................................................................................................................................................................................................................... 18 SCHOOLER2005 .......................................................................................................................................................................................................................................... 20 VANNIMWEGEN2008 ............................................................................................................................................................................................................................... 23 References of included studies (update) ................................................................................................................................................................................................... 25 Acute treatment with antipsychotic medication ......................................................................................................................................................................................... 28 Characteristics of included studies (previous guideline) ....................................................................................................................................................................... 28 Arvanitis1997 ................................................................................................................................................................................................................................................ 28 Barnas1987 .................................................................................................................................................................................................................................................... 29 Beasley1996a ................................................................................................................................................................................................................................................. 29 Beasley1997 ................................................................................................................................................................................................................................................... 31 Blin1996 ......................................................................................................................................................................................................................................................... 32 Carriere2000 .................................................................................................................................................................................................................................................. 33 1 Appendix 22b Study characteristics tables: Pharmacology Ceskova1993 ................................................................................................................................................................................................................................................. 34 Cetin1999 ....................................................................................................................................................................................................................................................... 35 Chouinard1993 ............................................................................................................................................................................................................................................. 36 Claus1991 ...................................................................................................................................................................................................................................................... 37 Conley2001.................................................................................................................................................................................................................................................... 37 Cooper1999a ................................................................................................................................................................................................................................................. 39 Delcker1990 .................................................................................................................................................................................................................................................. 40 Dieterle1999 .................................................................................................................................................................................................................................................. 41 Fleischhacker1989 ........................................................................................................................................................................................................................................ 41 Fleischhacker1996 ........................................................................................................................................................................................................................................ 41 Fleurot1997 ................................................................................................................................................................................................................................................... 42 Gureje1998 .................................................................................................................................................................................................................................................... 42 Hale2000 ........................................................................................................................................................................................................................................................ 43 HGBL1997 ....................................................................................................................................................................................................................................................